Immune Therapeutics, Inc. Uncategorized Contracts & Agreements
19 Contracts & Agreements
- [REVISED CYTOCOM AGREEMENT] (Filed With SEC on August 16, 2021)
- Letter of Intent, dated May 25, 2021 (Filed With SEC on June 2, 2021)
- Board Resolution dated July 24, 2020 (Filed With SEC on July 27, 2020)
- Board Resolution dated April 30, 2020 (Filed With SEC on May 5, 2020)
- Letter of Intent dated March 17, 2020 (Filed With SEC on March 20, 2020)
- Board Resolution (Filed With SEC on February 19, 2020)
- Restated Agreement (Filed With SEC on June 11, 2018)
- Extension of AHAR Agreement dated March 29, 2016 (Filed With SEC on April 2, 2018)
- Real Property Leases for Florida Office and Extensions dated July 19, 2017 and November 13, 2017 (Filed With SEC on April 2, 2018)
- EXCLUSIVEAGENCY AGREEMENT (Filed With SEC on November 15, 2016)
- CONTRACTFOR THE MANUFACTURING OF PHARMACEUTICAL PRODUCTS (Filed With SEC on November 15, 2016)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 15, 2016)
- CONTRACTFOR THE COMPOUNDING OF PHARMACEUTICAL PRODUCTS (Filed With SEC on May 20, 2016)
- LODONAL" IN THE TREATMENT OF SUBJECTS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) A Bridging Study to Evaluate the Effects of LODONAL" as an Immune-System Regulating Agent in Subjects... (Filed With SEC on December 4, 2015)
- ROYALTY AGREEMENT (Filed With SEC on May 21, 2015)
- Contract for the Compounding of Pharmaceutical Products, dated December 8, 2014 (Filed With SEC on December 15, 2014)
- Exhibit 10.1 Clinical Trial Agreement dated October 20, 2014 between TNI BioTech International Ltd. and American Hospital and Resorts (Filed With SEC on October 30, 2014)
- Exhibit 10.17 (Filed With SEC on March 31, 2014)
- Exhibit 10.16 1 2 3 4 5 6 7 (Filed With SEC on March 31, 2014)
